Novartis wins USFDA approval for first PI3K inhibitor for breast cancer Farhat Nasim27 May 2019 6:10 PM ISTThe drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names Farhat Nasim17 May 2019 5:37 PM ISTNew Delhi: In a major setback to many pharma companies in the country, the ruling Government is reported to have directed state drug controllers to...
